Difference between revisions of "Workshop on Clinical Trial Ontology"

From NCBO Wiki
Jump to navigation Jump to search
m
 
(150 intermediate revisions by 6 users not shown)
Line 1: Line 1:
== General Information ==
+
== '''General Information''' ==
  
The National Center for Biomedical Ontology will host a two-day workshop focused on the Ontology of Clinical Trials. The workshop will take place on May 16-17, 2007 at the NIH Campus in Bethesda, MD. We are grateful to the National Heart, Lung and Blood Institute for generous support.
+
The National Center for Biomedical Ontology will host a two-day workshop focused on the Ontology of Clinical Trials. The workshop will take place on May 16-17, 2007 at the NIH Campus in Bethesda, MD.  
  
== Aim of the Workshop ==
+
The meeting will be divided into two parts. Day 1 will be a public event consisting of presentations and panel discussions on the CTO and cognate initiatives. Day 2 will be a working meeting devoted to intense discussions of mature drafts of the CTO and to the creation of a strategy for its further development and testing.
 +
 
 +
The work of the NCBO is funded by the National Institutes of Health through the NIH Roadmap for Medical Research, Grant 1 U 54 HG004028. Information on the National Centers for Biomedical Computing can be found [http://nihroadmap.nih.gov/bioinformatics here].
 +
 
 +
We are grateful to the National Heart, Lung and Blood Institute for generous support for this meeting.
 +
 
 +
== '''Aim of the Workshop''' ==
  
 
The aim of the workshop is to foster the creation and dissemination of a reference ontology (high-quality controlled structured vocabulary) for the annotation of the results of clinical trials.  
 
The aim of the workshop is to foster the creation and dissemination of a reference ontology (high-quality controlled structured vocabulary) for the annotation of the results of clinical trials.  
  
The Workshop will bring together representatives of all of the major groups involved in clinical trial informatics, design, execution, analysis and standardization, with the goal of achieving a broad consensus on the requirements which the ontology should address and on the most effective means of realizing these requirements.
+
The Workshop will bring together representatives of all of the major groups involved in clinical trial informatics, design, execution, analysis and standardization, with the goal of achieving a broad consensus on the requirements which the ontology should address and on the most effective means of realizing these requirements. It will address the potential uses of CTO, and methodology for CTO design and development.
  
== Goals of the Clinical Trial Ontology Initiative==
+
== '''Goals of the Clinical Trial Ontology Initiative''' ==
  
 
The proposed CTO should:
 
The proposed CTO should:
Line 15: Line 21:
 
(1) fully and faithfully capture the types of entities and relationships involved in clinical trials of any experimental design
 
(1) fully and faithfully capture the types of entities and relationships involved in clinical trials of any experimental design
  
(2) comprehend terms like: ''cohort, randomization, placebo, response, efficacy, control, protocol, null hypothesis, confidence interval, finding, biomarker, primary outcome, secondary outcome, intervention group, experimental design,'' etc., including also major relevant statistical terms and terms drawn from resources such as the CDISC [http://www.cdisc.org/glossary/clinicalterminologyv4.pdf glossary] and  
+
(2) comprehend terms like: ''cohort, randomization, placebo, response, efficacy, control, protocol, null hypothesis, confidence interval, finding, biomarker, primary outcome, secondary outcome, intervention group, confounder,'' etc., including also major relevant statistical terms and terms drawn from resources such as the CDISC [http://www.cdisc.org/glossary/clinicalterminologyv4.pdf glossary] and  
 
all terms needed for the task of meta-analysis of clinical trials;  
 
all terms needed for the task of meta-analysis of clinical trials;  
  
Line 24: Line 30:
 
(5) form an integral part of the more comprehensive framework of the Ontology for Biomedical Investigations [http://obi.sourceforge.net/ OBI], which itself forms part of the [http://obofoundry.org/ OBO Foundry]
 
(5) form an integral part of the more comprehensive framework of the Ontology for Biomedical Investigations [http://obi.sourceforge.net/ OBI], which itself forms part of the [http://obofoundry.org/ OBO Foundry]
  
(6) draw on and seek maximal alignment with existing clinical trial ontologies, including the [http://smi.stanford.edu/smi-web/research/details.jsp?PubId=1227 Epoch ontology] used by the [http://www.immunetolerance.org/ Immune Tolerance Network] and the[http://rctbank.ucsf.edu/ontology/outline/index.htm RCT Schema] ontology used by the[http://rctbank.ucsf.edu/ Trial Bank Initiative]
+
(6) draw on and seek maximal alignment with existing clinical trial ontologies, including:
  
(7) rest on a clear understanding of the relation between CTO and an epidemiology study ontology
+
-- the [http://smi.stanford.edu/smi-web/research/details.jsp?PubId=1227 Epoch ontology] used by the [http://www.immunetolerance.org Immune Tolerance Network]
  
(8) rest on a clear understanding of the relation between CTO and data-model-oriented initiatives such as CDISC and BRIDG.
+
-- the [http://rctbank.ucsf.edu/ontology/outline/index.htm RCT Schema] ontology used by the[http://rctbank.ucsf.edu/ Trial Bank Initiative]
  
(9) meet the requirements of the [http://obofoundry.org OBO Foundry], and in particular support an adequate treatment of the distinction between ''types'' (''surgical intervention'', ''tumor'', ''human being'') and ''instances'' (Jane's oophorectomy, John's tumor, Fritz)
+
(7) rest on a clear understanding of the relation between CTO and related ventures such as an epidemiology study ontology
  
== Agenda [Draft] ==
+
(8) rest on a clear understanding of the relation between CTO and data-model-oriented initiatives such as CDISC and BRIDG
  
The meeting will be divided into two parts:
+
(9) be created through an open process, in which all interested parties can be involved.
  
'''Day 1''' will be a public event consisting of presentations and panel discussions on the CTO and cognate initiatives.
+
== '''Agenda''' ==
  
'''Day 2''' will be a working meeting devoted to intense discussions of mature drafts of the CTO and to the creation of a strategy for its further development and testing.
+
'''<big><u>Wednesday, May 16 - Building 45 (Natcher), Balcony A</u></big>'''
  
Please note that active participation in Day 2 of the meeting is restricted. If you wish to be considered for participation, please send a brief statement to [mailto:phismith@buffalo.edu Barry Smith].
+
* 8:00am -- Registration & Continental Breakfast
  
Observers will be welcome in both parts of the meeting providing they give prior notice, details concerning which will be provided in due course.
+
'''Session 1 (Chair: Barry Smith)'''
  
----
+
* 9:00am -- Carol Bean: ''Introduction''
  
'''May 16  Natcher Balcony A'''
+
* 9:10am -- Susan Shurin, Deputy Director of the National Heart Lung and Blood Institute: ''Welcome''
  
8.00am  Continental Breakfast
+
* 9:20am -- Werner Ceusters: ''How to Build an Ontology'' [http://ontology.buffalo.edu/07/CTO/ceusters.ppt ppt]
  
9.00am Carol Bean: Introduction
+
* 10:00am -- Discussion
  
9.10am  Susan Shurin, Deputy Director of the National Heart Lung and Blood Institute: Welcome
+
* 10:15am -- Refreshment Break
  
9.20am Werner Ceusters: How to Build an Ontology
+
'''Session 2 (Chair: Dave Parrish)'''
  
10.00am Discussion
+
* 10:30am -- Chris Mungall: ''The OBO Foundry'' [http://ontology.buffalo.edu/07/CTO/mungall.ppt ppt]
  
10.15am Coffee
+
* 11:00am -- Jennifer Fostel: ''The Ontology for Biomedical Investigations'' [http://ontology.buffalo.edu/07/CTO/fostel.ppt ppt]
  
10.30am Suzanna Lewis: The OBO Foundry
+
* 11:30am -- Richard Scheuermann: ''Introducing the Clinical Trial Ontology'' [http://ontology.buffalo.edu/07/CTO/scheuermann.ppt  ppt]
  
11.00am Jennifer Fostel: The Ontology for Biomedical Investigations
+
* 12:00pm -- Discussion
  
11.30am  Richard Scheuermann: Introducing the Clinical Trial Ontology
+
* 12:30pm -- Lunch Break
  
12.00 noon Discussion
+
'''Session 3 (Chair: Werner Ceusters)'''
  
12.30 Lunch
+
* 1:30pm -- Ida Sim: ''The RCT Schema'' [http://ontology.buffalo.edu/07/CTO/sim.ppt  ppt]
  
1.30pm Ida Sim: The RCT Schema
+
* 2:00pm -- Amar Das: ''Epoch: An Ontological Framework for Clinical Trial Management''
 +
[http://ontology.buffalo.edu/07/CTO/Das.pdf ppt]
  
2.00pm Amar Das: Epoch: An Ontological Framework for Clinical Trial Management
+
* 2:30pm -- Barry Smith: ''The Clinical Trial Ontology: Creating Consensus'' [http://ontology.buffalo.edu/07/CTO/smith.ppt  ppt]
  
2.30pm Barry Smith: The Clinical Trial Ontology: Creating Consensus
+
* 3:30pm -- Refreshment Break
  
3.00pm Discussion
+
* 4:00pm -- Discussion Session
  
3.30pm Coffee
+
* 5:00pm -- Close
  
4.00pm Panel Session
 
  
5.00pm Close
+
'''<big><u>Thursday, May 17 - Building 31, Conference Room 10</u></big>'''
  
----
+
* 8:00am -- Registration & Continental Breakfast
  
'''May 17  Building 31 Conference Room 10'''
+
'''Session 4 (Moderator: Jennifer Fostel)'''  
  
8.00am Continental Breakfast
+
* 9:00am -- Building the Clinical Trial Ontology
  
9.00am Session 1: Building the Clinical Trial Ontology
+
* 10:30am -- Refreshment Break
  
11.00am Session 2: Applying the Clinical Trial Ontology
+
''' Session 5 (Moderator: Alan Ruttenberg)'''
  
12.30 noon  Lunch
+
* 11:00am -- Applying the Clinical Trial Ontology
 +
**Norbert Graf: ACGT's Clinical Trial Builder [http://ontology.buffalo.edu/07/CTO/graf.ppt ppt]
  
1.30pm Session 3: The Future of the Clinical Trial Ontology
+
* 12:30pm -- Lunch Break
  
4.00pm Close
+
'''Session 6 (Moderator: Richard Scheuermann)'''
  
== Active Participants ==
+
* 1:30pm -- The Future of the Clinical Trial Ontology [[Media:CTO_Workshop_Day_2_RS_JL.doc]]
  
'''All participants will be required to register. Registration details will be available in due course.'''
+
* 3:00pm -- Close
  
Sivaram Arabandi -- Cleveland Clinic
+
== '''NIH Security Regulations''' ==
  
Charles E. Barr -- AMIA Clinical Trial Working Group
+
All visitor vehicles, including taxicabs, hotel and airport shuttles, delivery trucks and vans will be inspected before being allowed on campus. Visitors will be asked to show a form of government-issued photo identification (driver's license, passport, green card, etc.) and to state the purpose of their visit. Be sure to allow extra time for this vehicle inspection procedure. Employees and visitors should continue to wear their identification prominently at all times while on campus.
 +
 +
Guards will remain at certain buildings to address specific program requirements such as sensitive research and safety concerns. At building entrances where guards are posted:
 +
* Visitors may be required to log in, wear a visitors pass and have an employee escort them through the building.
 +
* Visitors may be required to pass through a metal detector and have bags, backpacks or purses inspected or x-rayed as they enter buildings.
 +
Security staff will be looking for and confiscating any suspicious or potentially dangerous materials. U.S. Code prohibits bringing any dangerous weapons onto Federal property, including anything with a blade longer than 2½ inches. Meeting participants may want to leave extra bags or personal materials at their hotel to minimize the time needed for inspection.
  
Carol Bean -- NIH/NHLBI
+
All visitors including patients, contractors, vendors and delivery persons must use the following entrances:
 +
 +
<u>Rockville Pike at South Drive</u> (Metro):
 +
* Open 24 hours - Inbound and Outbound traffic
 +
* Open to All Vehicles
 +
* Pedestrian Turnstiles Open for Employees
 +
* Gateway Center at Metro Open for Visitor Registration--this is where visitors check-in with security if they are not driving
  
Mathias Brochhausen -- IFOMIS / European Center for Ontological Research, Saarbrücken
+
<u>Old Georgetown Road at Center Drive</u> (This entrance is primarily for commercial vehicles and visitors):
 +
* 6am- 7pm -Inbound and Outbound Traffic
 +
* Open to Employee, Commercial and Visitor Vehicles
 +
* Pedestrian Turnstiles Open for Employees
 +
 +
Please note: Visitor parking is limited at NIH. Visitors are encouraged to use public transportation such as the Metrorail subway system which has a convenient stop (Medical Center) on the NIH campus.
 +
 
 +
Visitors arriving by bus will be dropped off at the NIH/Medical Center Metro stop at Rockville Pike and South Drive. Patients and visitors on official business can then ride the Campus Shuttle to the Clinical Center and other designated shuttle stops on the campus.
 +
 
 +
== '''Participants (Final)''' ==
 +
 
 +
Robert Arp -- NCBO, University at Buffalo
 +
 
 +
Elaine Ayres -- NIH / Clinical Center
 +
 
 +
William Barrick -- National Institute of Allergy and Infectious Diseases (NIAID) / NIH
 +
 
 +
Carol Bean -- National Heart, Lung and Blood Institute (NHLBI) / NIH
 +
 
 +
Maureen Beanan -- National Center for Research Resources (NCRR) / NIH
 +
 
 +
Elmer Bernstam -- University of Texas Health Science Center at Houston
 +
 
 +
Olivier Bodenreider -- National Library of Medicine (NLM) / NIH
 +
 
 +
Olga Brazhnik -- National Center for Research Resources (NCRR) / NIH
 +
 
 +
Constantino Castillo -- The KEVRIC Company, Inc.
  
 
Werner Ceusters -- Ontology Research Group, University at Buffalo
 
Werner Ceusters -- Ontology Research Group, University at Buffalo
  
Chris Chute -- NCBO, Mayo Clinic, Rochester, MN
+
Huey Cheung -- Center for Information Technology (CIT) / NIH
 +
 
 +
Ling Chin -- National Institute on Deafness and Other Communication Disorders (NIDCD) / NIH
 +
 
 +
In Hye Cho -- National Library of Medicine (NLM) / NIH
 +
 
 +
Christopher G. Chute -- NCBO, Mayo Clinic
 +
 
 +
Kevin Clany -- Invitrogen Corp.
 +
 
 +
Christian Cocos -- IFOMIS (Saarbrücken, Germany)
 +
 
 +
Elaine Collier -- National Center for Research Resources (NCRR) / NIH
  
Leo Cousineau -- Information Management Consultants, Reston, VA
+
Leo Cousineau -- Information Management Consultants (Reston, VA)
  
Lindsay Cowell -- Duke University
+
Lindsay Cowell -- Duke University Medical Center
  
 
Amar Das -- Stanford Medical Informatics
 
Amar Das -- Stanford Medical Informatics
  
 
Kaushal Desai -- AstraZeneca  
 
Kaushal Desai -- AstraZeneca  
 +
 +
Stephen Dobson -- Pfizer Global Research and Development
  
 
Liju Fan -- Ontology Workshop, LLC
 
Liju Fan -- Ontology Workshop, LLC
 +
 +
Gabriele Feolo -- National Heart, Lung and Blood Institute (NHLBI) / NIH
  
 
Kerstin Forsberg -- AstraZeneca
 
Kerstin Forsberg -- AstraZeneca
Line 130: Line 191:
 
Jennifer Fostel -- NIH/NIEHS
 
Jennifer Fostel -- NIH/NIEHS
  
Gilberto Fragoso -- NIH/NCI
+
Douglas Fridsma -- University of Pittsburgh
  
Douglas Fridsma -- University of Pittsburgh
+
Jane Fun -- Contractor, National Library of Medicine (NLM) / NIH
  
 
Louis J. Goldberg -- University at Buffalo
 
Louis J. Goldberg -- University at Buffalo
  
Federico Goodsaid -- (FDA CDER, Office of Clinical Pharmacology)
+
Peter Good -- National Human Genome Research Institute (NHGRI) / NIH
  
Norbert Graf -- [http://acgt.ercim.org/ ACGT], Homburg, Germany
+
Norbert Graf -- Clinic for Paediatric Oncology and Haematology, Saarland University (Homburg, Germany)
  
Ted Grasela -- Cognigen Corporation, Amherst, NY
+
Lakshmi M. Grama -- National Cancer Institute (NCI) / NIH
 +
 
 +
Ted Grasela -- Cognigen Corporation (Amherst, NY)
  
 
Herb Hagler -- University of Texas Southwestern Medical Center
 
Herb Hagler -- University of Texas Southwestern Medical Center
 +
 +
Andrea Harabin -- National Heart, Lung and Blood Institute (NHLBI) / NIH
 +
 +
William Harlan -- Consultant, National Library of Medicine (NLM) / NIH
  
 
Steve Harris -- Computing Laboratory, University of Oxford
 
Steve Harris -- Computing Laboratory, University of Oxford
  
Tina Hernandez-Boussard -- PharmGKB, Stanford University
+
Frank Hartel -- NCI Center for Bioinformatics / NIH
 +
 
 +
Calvin A. Johnson -- Center for Information Technology (CIT) / NIH
 +
 
 +
Heather A. Junkins -- CRIIT & NHLBI / NIH
 +
 
 +
Webster Kelsey -- Dept of Biomedical Informatics, University of Pittsburgh
  
 
Warren A. Kibbe -- Northwestern University
 
Warren A. Kibbe -- Northwestern University
  
Randy Levin -- CDER
+
Bron W. Kisler -- Clinical Data Interchange Standards Consortium (CDISC)
 +
 
 +
George A. Komatsoulis -- NCI Center for Bioinformatics / NIH
 +
 
 +
Jennie Larkin -- National Heart, Lung and Blood Institute (NHLBI) / NIH
 +
 
 +
William Lau -- Center for Information Technology (CIT) / NIH
 +
 
 +
Jamie Lee -- University of Texas Southwestern Medical Center at Dallas
 +
 
 +
Natasha Levenkov -- Rockefeller University
 +
 
 +
Yuan Liu -- National Institute of Neurological Diseases and Stroke (NINDS) / NIH
 +
 
 +
Yun Lu -- KAI Research, Inc.
 +
 
 +
Dan Lyman -- Information Management Consultants (Reston, VA)
 +
 
 +
Peter Lyster -- Center for Bioinformatics and Computational Biology, National Institute of General Medical Sciences (NIGMS) / NIH
 +
 
 +
Peter Maccallum -- CRUK Cambridge Research Institute, University of Cambridge
  
Jamie Lee -- University of Texas Southwestern Medical Center
+
Charles Mead -- NCI/NIH, Center for Biomedical Informatics and Information Technology
  
Suzanna Lewis -- NCBO, Berkeley, CA
+
Chris Mungall -- NCBO, Lawrence Berkeley National Laboratory
  
Eric Little -- Center for Ontology and Interdisciplinary Studies
+
Robert A. Musson -- National Heart, Lung and Blood Institute (NHLBI) / NIH
  
Dan Lyman -- Information Management Consultants, Reston, VA
+
Darren Natale -- Georgetown University Medical Center
  
Peter Maccallum -- UK CancerGrid, Department of Oncology, University of Cambridge
+
Fabian Neuhaus -– National Institute of Standards and Technology (NIST)
  
Charles Mead -- NCI Center for Biomedical Informatics and Information Technology
+
Eric Neumann -- Teranode (Seattle, WA)
  
Chris Mungall -- Howard Hughes Institute, Berkeley, CA
+
Eduardo Ortiz -- National Heart, Lung and Blood Institute (NHLBI) / NIH
  
Mark Musen -- NCBO, Stanford University, CA
+
Jeng-Jong Pan -- National Institute on Drug Abuse (NIDA) / NIH
  
Fabian Neuhaus -– NCBO, University at Buffalo, NY
+
Dave Parrish -- Immune Tolerance Network (Pittsburgh, PA)
  
Chimezie Ogbuji -- Cleveland Clinic Foundation, OH
+
George O. Redmond -- National Cancer Institute (NCI) / NIH
  
Dave Parrish -- Immune Tolerance Network, Pittsburgh, PA
+
Dianne M. Reeves -- National Cancer Institute, Center for Biomedical Informatics and Information Technology (formerly NCICB) / NIH
  
Philippe Rocca-Serra -- EBI, Hinxton, Cambridge
+
Alan Ruttenberg -- Science Commons (c/o MIT CSAIL)
  
Susanna Sansone -- EBI, Hinxton, Cambridge
+
Jody Sachs -- National Center for Research Resources (NCRR) / NIH
  
Nigam Shah -– NCBO, Stanford Medical Informatics
+
Michael Sayre -- National Center for Research Resources (NCRR) / NIH
  
 
Richard Scheuermann -- University of Texas Southwestern Medical Center
 
Richard Scheuermann -- University of Texas Southwestern Medical Center
 +
 +
Susan Shurin -- National Heart, Lung and Blood Institute (NHLBI) / NIH
 +
 +
Hua-Chuan Sim -- National Library of Medicine (NLM) / NIH
  
 
Ida Sim -- Trial Bank, University of California at San Francisco Medical Center
 
Ida Sim -- Trial Bank, University of California at San Francisco Medical Center
  
Barry Smith -NCBO, University at Buffalo, NY
+
Barry Smith -- NCBO, University at Buffalo
 +
 
 +
Ranjana Srivastava -- Information Management Consultants (Reston, VA)
  
Ranjana Srivastava -- Information Management Consultants, Reston, VA
+
Samson Tu -- Stanford University
  
Holger Stenzhorn -- IFOMIS, Saarbrücken
+
Suresh Varghese -- Digital Infuzion, Inc.
  
Weida Tong -- Center for Toxicoinformatics, FDA NCTR
+
Chunhua Weng -- University of Pittsburgh
  
Trish Whetzel -- University of Pennsylvania
+
Rebecca Williams -- National Library of Medicine (NLM) / NIH
  
Samson Tu -- Stanford University
+
Ashley Xia -- National Institute of Allergy and Infectious Diseases (NIAID) / NIH
  
Gabriele Weiler -- Fraunhofer Institute, Sankt Ingbert, Germany
+
Sandhya Xirasagar -- Information Management Consultants (Reston, VA)
  
Chunhua Weng -- University of Pittsburgh
+
Alison Yao -- National Institute of Allergy and Infectious Diseases (NIAID) / NIH
  
Sandhya Xirasagar -- Information Management Consultants
+
Zhensheng Zhang -- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) / NIH
  
== Venue ==
+
== '''Venue''' ==
  
 
Day 1: Balcony A, Building 45 (Natcher), NIH Campus, Bethesda, MD
 
Day 1: Balcony A, Building 45 (Natcher), NIH Campus, Bethesda, MD
Line 208: Line 307:
 
Day 2: Conference Room 10, Building 31, NIH Campus, Bethesda, MD
 
Day 2: Conference Room 10, Building 31, NIH Campus, Bethesda, MD
  
[http://www.nih.gov/about/visitor/index.htm Travel to NIH Campus]
+
A printable NIH Visitors Map can be found at: [http://parking.nih.gov/documents/visitorAccessMap.pdf NIH Visitors Map]
  
== Links ==
+
A printable schedule of shuttle service between area hotels and NIH can be found at:  [http://dtts.ors.od.nih.gov/documents/south_hotel_shuttles.pdf NIH Shuttles]
 +
 
 +
== '''Links''' ==
  
 
[http://www.bioontology.org/ncbo/faces/index.xhtml NCBO Bioportal]
 
[http://www.bioontology.org/ncbo/faces/index.xhtml NCBO Bioportal]
Line 227: Line 328:
  
 
[http://www.bioontology.org/wiki/index.php/CTO:Main_Page Clinical Trial Ontology Wiki]
 
[http://www.bioontology.org/wiki/index.php/CTO:Main_Page Clinical Trial Ontology Wiki]
 +
 +
[http://esw.w3.org/topic/HCLS/OntologyTaskForce/BIONTDSEDCM HCLS Ontology Task Force]
  
 
A video introduction to ontologies by Barry Smith is available here:
 
A video introduction to ontologies by Barry Smith is available here:
Line 236: Line 339:
 
The second half of this presentation pertains to the building of the Clinical Trial Ontology.
 
The second half of this presentation pertains to the building of the Clinical Trial Ontology.
  
== Preliminary Fragment of CTO (for illustration purposes only) ==
+
== '''Preliminary Fragment of CTO''' (for illustration purposes only) ==
  
 
[http://cto.googlecode.com/svn/trunk/CTO.owl Current OWL version]
 
[http://cto.googlecode.com/svn/trunk/CTO.owl Current OWL version]
  
 
[[Image:CTO.jpg]]
 
[[Image:CTO.jpg]]

Latest revision as of 10:38, 6 August 2008

General Information

The National Center for Biomedical Ontology will host a two-day workshop focused on the Ontology of Clinical Trials. The workshop will take place on May 16-17, 2007 at the NIH Campus in Bethesda, MD.

The meeting will be divided into two parts. Day 1 will be a public event consisting of presentations and panel discussions on the CTO and cognate initiatives. Day 2 will be a working meeting devoted to intense discussions of mature drafts of the CTO and to the creation of a strategy for its further development and testing.

The work of the NCBO is funded by the National Institutes of Health through the NIH Roadmap for Medical Research, Grant 1 U 54 HG004028. Information on the National Centers for Biomedical Computing can be found here.

We are grateful to the National Heart, Lung and Blood Institute for generous support for this meeting.

Aim of the Workshop

The aim of the workshop is to foster the creation and dissemination of a reference ontology (high-quality controlled structured vocabulary) for the annotation of the results of clinical trials.

The Workshop will bring together representatives of all of the major groups involved in clinical trial informatics, design, execution, analysis and standardization, with the goal of achieving a broad consensus on the requirements which the ontology should address and on the most effective means of realizing these requirements. It will address the potential uses of CTO, and methodology for CTO design and development.

Goals of the Clinical Trial Ontology Initiative

The proposed CTO should:

(1) fully and faithfully capture the types of entities and relationships involved in clinical trials of any experimental design

(2) comprehend terms like: cohort, randomization, placebo, response, efficacy, control, protocol, null hypothesis, confidence interval, finding, biomarker, primary outcome, secondary outcome, intervention group, confounder, etc., including also major relevant statistical terms and terms drawn from resources such as the CDISC glossary and all terms needed for the task of meta-analysis of clinical trials;

(3) organize these terms in a structured way, providing definitions and logical relations designed to enhance retrieval of, reasoning with, and integration of the data annotated in its terms.

(4) support trial bank interoperation

(5) form an integral part of the more comprehensive framework of the Ontology for Biomedical Investigations OBI, which itself forms part of the OBO Foundry

(6) draw on and seek maximal alignment with existing clinical trial ontologies, including:

-- the Epoch ontology used by the Immune Tolerance Network

-- the RCT Schema ontology used by theTrial Bank Initiative

(7) rest on a clear understanding of the relation between CTO and related ventures such as an epidemiology study ontology

(8) rest on a clear understanding of the relation between CTO and data-model-oriented initiatives such as CDISC and BRIDG

(9) be created through an open process, in which all interested parties can be involved.

Agenda

Wednesday, May 16 - Building 45 (Natcher), Balcony A

  • 8:00am -- Registration & Continental Breakfast

Session 1 (Chair: Barry Smith)

  • 9:00am -- Carol Bean: Introduction
  • 9:10am -- Susan Shurin, Deputy Director of the National Heart Lung and Blood Institute: Welcome
  • 9:20am -- Werner Ceusters: How to Build an Ontology ppt
  • 10:00am -- Discussion
  • 10:15am -- Refreshment Break

Session 2 (Chair: Dave Parrish)

  • 10:30am -- Chris Mungall: The OBO Foundry ppt
  • 11:00am -- Jennifer Fostel: The Ontology for Biomedical Investigations ppt
  • 11:30am -- Richard Scheuermann: Introducing the Clinical Trial Ontology ppt
  • 12:00pm -- Discussion
  • 12:30pm -- Lunch Break

Session 3 (Chair: Werner Ceusters)

  • 1:30pm -- Ida Sim: The RCT Schema ppt
  • 2:00pm -- Amar Das: Epoch: An Ontological Framework for Clinical Trial Management

ppt

  • 2:30pm -- Barry Smith: The Clinical Trial Ontology: Creating Consensus ppt
  • 3:30pm -- Refreshment Break
  • 4:00pm -- Discussion Session
  • 5:00pm -- Close


Thursday, May 17 - Building 31, Conference Room 10

  • 8:00am -- Registration & Continental Breakfast

Session 4 (Moderator: Jennifer Fostel)

  • 9:00am -- Building the Clinical Trial Ontology
  • 10:30am -- Refreshment Break

Session 5 (Moderator: Alan Ruttenberg)

  • 11:00am -- Applying the Clinical Trial Ontology
    • Norbert Graf: ACGT's Clinical Trial Builder ppt
  • 12:30pm -- Lunch Break

Session 6 (Moderator: Richard Scheuermann)

  • 3:00pm -- Close

NIH Security Regulations

All visitor vehicles, including taxicabs, hotel and airport shuttles, delivery trucks and vans will be inspected before being allowed on campus. Visitors will be asked to show a form of government-issued photo identification (driver's license, passport, green card, etc.) and to state the purpose of their visit. Be sure to allow extra time for this vehicle inspection procedure. Employees and visitors should continue to wear their identification prominently at all times while on campus.

Guards will remain at certain buildings to address specific program requirements such as sensitive research and safety concerns. At building entrances where guards are posted:

  • Visitors may be required to log in, wear a visitors pass and have an employee escort them through the building.
  • Visitors may be required to pass through a metal detector and have bags, backpacks or purses inspected or x-rayed as they enter buildings.

Security staff will be looking for and confiscating any suspicious or potentially dangerous materials. U.S. Code prohibits bringing any dangerous weapons onto Federal property, including anything with a blade longer than 2½ inches. Meeting participants may want to leave extra bags or personal materials at their hotel to minimize the time needed for inspection.

All visitors including patients, contractors, vendors and delivery persons must use the following entrances:

Rockville Pike at South Drive (Metro):

  • Open 24 hours - Inbound and Outbound traffic
  • Open to All Vehicles
  • Pedestrian Turnstiles Open for Employees
  • Gateway Center at Metro Open for Visitor Registration--this is where visitors check-in with security if they are not driving

Old Georgetown Road at Center Drive (This entrance is primarily for commercial vehicles and visitors):

  • 6am- 7pm -Inbound and Outbound Traffic
  • Open to Employee, Commercial and Visitor Vehicles
  • Pedestrian Turnstiles Open for Employees

Please note: Visitor parking is limited at NIH. Visitors are encouraged to use public transportation such as the Metrorail subway system which has a convenient stop (Medical Center) on the NIH campus.

Visitors arriving by bus will be dropped off at the NIH/Medical Center Metro stop at Rockville Pike and South Drive. Patients and visitors on official business can then ride the Campus Shuttle to the Clinical Center and other designated shuttle stops on the campus.

Participants (Final)

Robert Arp -- NCBO, University at Buffalo

Elaine Ayres -- NIH / Clinical Center

William Barrick -- National Institute of Allergy and Infectious Diseases (NIAID) / NIH

Carol Bean -- National Heart, Lung and Blood Institute (NHLBI) / NIH

Maureen Beanan -- National Center for Research Resources (NCRR) / NIH

Elmer Bernstam -- University of Texas Health Science Center at Houston

Olivier Bodenreider -- National Library of Medicine (NLM) / NIH

Olga Brazhnik -- National Center for Research Resources (NCRR) / NIH

Constantino Castillo -- The KEVRIC Company, Inc.

Werner Ceusters -- Ontology Research Group, University at Buffalo

Huey Cheung -- Center for Information Technology (CIT) / NIH

Ling Chin -- National Institute on Deafness and Other Communication Disorders (NIDCD) / NIH

In Hye Cho -- National Library of Medicine (NLM) / NIH

Christopher G. Chute -- NCBO, Mayo Clinic

Kevin Clany -- Invitrogen Corp.

Christian Cocos -- IFOMIS (Saarbrücken, Germany)

Elaine Collier -- National Center for Research Resources (NCRR) / NIH

Leo Cousineau -- Information Management Consultants (Reston, VA)

Lindsay Cowell -- Duke University Medical Center

Amar Das -- Stanford Medical Informatics

Kaushal Desai -- AstraZeneca

Stephen Dobson -- Pfizer Global Research and Development

Liju Fan -- Ontology Workshop, LLC

Gabriele Feolo -- National Heart, Lung and Blood Institute (NHLBI) / NIH

Kerstin Forsberg -- AstraZeneca

Jennifer Fostel -- NIH/NIEHS

Douglas Fridsma -- University of Pittsburgh

Jane Fun -- Contractor, National Library of Medicine (NLM) / NIH

Louis J. Goldberg -- University at Buffalo

Peter Good -- National Human Genome Research Institute (NHGRI) / NIH

Norbert Graf -- Clinic for Paediatric Oncology and Haematology, Saarland University (Homburg, Germany)

Lakshmi M. Grama -- National Cancer Institute (NCI) / NIH

Ted Grasela -- Cognigen Corporation (Amherst, NY)

Herb Hagler -- University of Texas Southwestern Medical Center

Andrea Harabin -- National Heart, Lung and Blood Institute (NHLBI) / NIH

William Harlan -- Consultant, National Library of Medicine (NLM) / NIH

Steve Harris -- Computing Laboratory, University of Oxford

Frank Hartel -- NCI Center for Bioinformatics / NIH

Calvin A. Johnson -- Center for Information Technology (CIT) / NIH

Heather A. Junkins -- CRIIT & NHLBI / NIH

Webster Kelsey -- Dept of Biomedical Informatics, University of Pittsburgh

Warren A. Kibbe -- Northwestern University

Bron W. Kisler -- Clinical Data Interchange Standards Consortium (CDISC)

George A. Komatsoulis -- NCI Center for Bioinformatics / NIH

Jennie Larkin -- National Heart, Lung and Blood Institute (NHLBI) / NIH

William Lau -- Center for Information Technology (CIT) / NIH

Jamie Lee -- University of Texas Southwestern Medical Center at Dallas

Natasha Levenkov -- Rockefeller University

Yuan Liu -- National Institute of Neurological Diseases and Stroke (NINDS) / NIH

Yun Lu -- KAI Research, Inc.

Dan Lyman -- Information Management Consultants (Reston, VA)

Peter Lyster -- Center for Bioinformatics and Computational Biology, National Institute of General Medical Sciences (NIGMS) / NIH

Peter Maccallum -- CRUK Cambridge Research Institute, University of Cambridge

Charles Mead -- NCI/NIH, Center for Biomedical Informatics and Information Technology

Chris Mungall -- NCBO, Lawrence Berkeley National Laboratory

Robert A. Musson -- National Heart, Lung and Blood Institute (NHLBI) / NIH

Darren Natale -- Georgetown University Medical Center

Fabian Neuhaus -– National Institute of Standards and Technology (NIST)

Eric Neumann -- Teranode (Seattle, WA)

Eduardo Ortiz -- National Heart, Lung and Blood Institute (NHLBI) / NIH

Jeng-Jong Pan -- National Institute on Drug Abuse (NIDA) / NIH

Dave Parrish -- Immune Tolerance Network (Pittsburgh, PA)

George O. Redmond -- National Cancer Institute (NCI) / NIH

Dianne M. Reeves -- National Cancer Institute, Center for Biomedical Informatics and Information Technology (formerly NCICB) / NIH

Alan Ruttenberg -- Science Commons (c/o MIT CSAIL)

Jody Sachs -- National Center for Research Resources (NCRR) / NIH

Michael Sayre -- National Center for Research Resources (NCRR) / NIH

Richard Scheuermann -- University of Texas Southwestern Medical Center

Susan Shurin -- National Heart, Lung and Blood Institute (NHLBI) / NIH

Hua-Chuan Sim -- National Library of Medicine (NLM) / NIH

Ida Sim -- Trial Bank, University of California at San Francisco Medical Center

Barry Smith -- NCBO, University at Buffalo

Ranjana Srivastava -- Information Management Consultants (Reston, VA)

Samson Tu -- Stanford University

Suresh Varghese -- Digital Infuzion, Inc.

Chunhua Weng -- University of Pittsburgh

Rebecca Williams -- National Library of Medicine (NLM) / NIH

Ashley Xia -- National Institute of Allergy and Infectious Diseases (NIAID) / NIH

Sandhya Xirasagar -- Information Management Consultants (Reston, VA)

Alison Yao -- National Institute of Allergy and Infectious Diseases (NIAID) / NIH

Zhensheng Zhang -- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) / NIH

Venue

Day 1: Balcony A, Building 45 (Natcher), NIH Campus, Bethesda, MD

Day 2: Conference Room 10, Building 31, NIH Campus, Bethesda, MD

A printable NIH Visitors Map can be found at: NIH Visitors Map

A printable schedule of shuttle service between area hotels and NIH can be found at: NIH Shuttles

Links

NCBO Bioportal

Open Biomedical Ontologies

OBO Foundry

Ontology for Biomedical Investigations

Trial Bank

Epoch Ontology

The ACGT Project: Advancing Clinico-Genomic Trials on Cancer

Clinical Trial Ontology Wiki

HCLS Ontology Task Force

A video introduction to ontologies by Barry Smith is available here:

  • Realmedia: rtsp://stream.buffalo.edu/shared/research/phismith/Stanford10-25-06/Tutorial.rm
  • Mediaplayer: rtsp://stream.buffalo.edu/shared/research/phismith/Stanford10-25-06/Tutorial.WMV

The second half of this presentation pertains to the building of the Clinical Trial Ontology.

Preliminary Fragment of CTO (for illustration purposes only)

Current OWL version

CTO.jpg